menu
    • menu

    Company profile for Centivax

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Centivax is a therapeutics company founded to treat and eradicate the remaining pathogens of the 21st century. We’re engineering medicines that matter at a price the world can afford. At Centivax, we apply our computational immunoengineering expertise to develop superior therapeutic monoclonal antibodies against the most challenging targets. On March 30th, we completed optimization of a panel of potent neutralizing anti...
    Centivax is a therapeutics company founded to treat and eradicate the remaining pathogens of the 21st century. We’re engineering medicines that matter at a price the world can afford. At Centivax, we apply our computational immunoengineering expertise to develop superior therapeutic monoclonal antibodies against the most challenging targets. On March 30th, we completed optimization of a panel of potent neutralizing antibodies proven to protect hamsters against SARS-CoV-2 (COVID-19). Actively looking for support for clinical development and distribution.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CentivaxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    201 Gateway Boulevard South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.centivax.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/centivax/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/centivax

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Centivax Secures $37M To Fast-Track Universal Flu Phase 2 Trial
    Centivax Secures $37M To Fast-Track Universal Flu Phase 2 Trial

    30 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/centivax-closes-37-million-financing-to-accelerate-phase-2-clinical-development-of-universal-flu-and-advance-follow-on-portfolio-to-clinical-readiness-302728654.html

    PR NEWSWIRE
    30 Mar 2026
    Share Share
    Centivax Launches Ph 1 Clinical Trial For Universal Flu Vaccine
    Centivax Launches Ph 1 Clinical Trial For Universal Flu Vaccine

    12 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/centivax-initiates-phase-1-first-in-human-clinical-trial-of-universal-flu-vaccine-302686585.html

    PR NEWSWIRE
    12 Feb 2026
    Share Share
    Centivax Secures $45M Series A for Flu Vaccine Development
    Centivax Secures $45M Series A for Flu Vaccine Development

    09 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/centivax-raises-oversubscribed-45-million-series-a-led-by-future-ventures-to-advance-universal-flu-vaccine-into-clinic-and-expand-universal-immunity-portfolio-302500567.html

    PR NEWSWIRE
    09 Jul 2025
    Share Share
    Centivax and Emery Pharma Partner to Accelerate Vaccine Clinical
    Centivax and Emery Pharma Partner to Accelerate Vaccine Clinical

    11 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/centivax-and-emery-pharma-partner-to-accelerate-universal-vaccine-clinical-readiness-302396089.html

    PR NEWSWIRE
    11 Mar 2025
    Share Share
    Centivax Raises $10M Seed Investment by NFX & GHIC to Develop Universal Vaccine
    Centivax Raises $10M Seed Investment by NFX & GHIC to Develop Universal Vaccine

    16 Nov 2022

    // WEBWIRE

    https://www.webwire.com/ViewPressRel.asp?aId=296685

    WEBWIRE
    16 Nov 2022
    Share Share
    Biotechnology Company Centivax Officially Launches
    Biotechnology Company Centivax Officially Launches

    29 Apr 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/biotechnology-company-centivax-officially-launches-301280683.html#:~:text=SAN%20FRANCISCO%2C%20April%2029%2C%202021,%2C%20influenza%2C%20antivenom%20and%20oncology.

    PRNEWSWIRE
    29 Apr 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search